Search Results - "Kitada, Munehiro"

Efficacy of luseogliflozin for renal function preservation in patients with type 2 diabetes mellitus and impaired renal function: A randomized open‐label clinical trial (RESOLUTION study).

Authors: Kitada, Munehiro Toyoda, Masao Sekine, Osamu et al.

Source: Journal of Diabetes Investigation. Dec2025, Vol. 16 Issue 12, p2160-2172. 13p.

Case report of superior mesenteric artery syndrome that developed in a lean type 2 diabetes patient and was associated with rapid body weight loss after sodium–glucose cotransporter 2 inhibitor administration.

Authors: Hirai, Taro Kitada, Munehiro Hayashi, Yoshihiro et al.

Source: Journal of Diabetes Investigation. Sep2020, Vol. 11 Issue 5, p1359-1362. 4p.

Sodium–glucose cotransporter 2 inhibitors in type 2 diabetes patients with renal function impairment slow the annual renal function decline, in a real clinical practice.

Authors: Hirai, Taro Kitada, Munehiro Monno, Itaru et al.

Source: Journal of Diabetes Investigation. Sep2021, Vol. 12 Issue 9, p1577-1585. 9p.

The Role of CD38 in the Pathogenesis of Cardiorenal Metabolic Disease and Aging, an Approach from Basic Research.

Authors: Kitada, Munehiro Araki, Shin-ichi Koya, Daisuke

Source: Cells (2073-4409). Feb2023, Vol. 12 Issue 4, p595. 22p.

Effect of switching to teneligliptin from other dipeptidyl peptidase‐4 inhibitors on glucose control and renoprotection in type 2 diabetes patients with diabetic kidney disease.

Authors: Kitada, Munehiro Ogura, Yoshio Nitta, Kyoko et al.

Source: Journal of Diabetes Investigation. May2019, Vol. 10 Issue 3, p706-713. 8p.

Renal mitochondrial oxidative stress is enhanced by the reduction of Sirt3 activity, in Zucker diabetic fatty rats.

Authors: Ogura, Yoshio Kitada, Munehiro Monno, Itaru et al.

Source: Redox Report. Dec2018, Vol. 23 Issue 1, p153-159. 7p.

Cyclic and intermittent very low-protein diet can have beneficial effects against advanced diabetic nephropathy in Wistar fatty ( fa/fa) rats, an animal model of type 2 diabetes and obesity.

Authors: Kitada, Munehiro Ogura, Yoshio Suzuki, Taeko et al.

Source: Nephrology. Dec2017, Vol. 22 Issue 12, p1030-1034. 5p.

CD‐1^db/db mice: A novel type 2 diabetic mouse model with progressive kidney fibrosis.

Authors: Mizunuma, Yuiko Kanasaki, Keizo Nitta, Kyoko et al.

Source: Journal of Diabetes Investigation. Nov2020, Vol. 11 Issue 6, p1470-1481. 12p.

This result is not displayed to guests.
Login for full access.

Endothelial FGFR1 (Fibroblast Growth Factor Receptor 1) Deficiency Contributes Differential Fibrogenic Effects in Kidney and Heart of Diabetic Mice.

Authors: Li, Jinpeng Liu, Haijie Srivastava, Swayam Prakash et al.

Source: Hypertension (0194911X). Dec2020, Vol. 76 Issue 6, p1935-1944.

Adenosine/adenosine type 1 receptor signaling pathway did not play dominant roles on the influence of sodium–glucose cotransporter 2 inhibitor in the kidney of bovine serum albumin‐overloaded streptozotocin‐induced diabetic mice

Authors: Shimada, Keiji Kanasaki, Keizo Kato, Makoto et al.

Source: Journal of Diabetes Investigation. Jun2022, Vol. 13 Issue 6, p955-964. 10p.

SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential.

Authors: Kitada, Munehiro Koya, Daisuke

Source: Diabetes & Metabolism Journal. Oct2013, Vol. 37 Issue 5, p315-325. 11p.

Pro-inflammatory macrophages coupled with glycolysis remodel adipose vasculature by producing platelet-derived growth factor-B in obesity.

Authors: Onogi, Yasuhiro Wada, Tsutomu Okekawa, Akira et al.

Source: Scientific Reports. 1/20/2020, Vol. 10 Issue 1, p1-13. 13p.

Dapagliflozin Restores Impaired Autophagy and Suppresses Inflammation in High Glucose-Treated HK-2 Cells.

Authors: Xu, Jing Kitada, Munehiro Ogura, Yoshio et al.

Source: Cells (2073-4409). Jun2021, Vol. 10 Issue 6, p1457-1457. 1p.

Severe electrolytes disorders with the interstitial kidney alterations in the patient with the history of total thyroidectomy and parathyroidectomy: possible role of vitamin D deficiency.

Authors: Kawakita, Emi Kanasaki, Keizo Hirai, Taro et al.

Source: Clinical Case Reports. Jun2018, Vol. 6 Issue 6, p983-989. 7p.

A low-protein diet exerts a beneficial effect on diabetic status and prevents diabetic nephropathy in Wistar fatty rats, an animal model of type 2 diabetes and obesity.

Authors: Kitada, Munehiro Ogura, Yoshio Suzuki, Taeko et al.

Source: Nutrition & Metabolism. 3/2/2018, Vol. 15, p1-1. 1p. 1 Color Photograph, 1 Chart, 4 Graphs.

Ipragliflozin improves mitochondrial abnormalities in renal tubules induced by a high‐fat diet.

Authors: Takagi, Susumu Li, Jinpeng Takagaki, Yuta et al.

Source: Journal of Diabetes Investigation. Sep2018, Vol. 9 Issue 5, p1025-1032. 8p.

Comparative Effects of Direct Renin Inhibitor and Angiotensin Receptor Blocker on Albuminuria in Hypertensive Patients with Type 2 Diabetes. A Randomized Controlled Trial.

Authors: Uzu, Takashi Araki, Shin-ichi Kashiwagi, Atsunori et al.

Source: PLoS ONE. 12/29/2016, Vol. 11 Issue 12, p1-11. 11p.

Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen.

Authors: Nitta, Kyoko Shi, Sen Nagai, Takako et al.

Source: BioMed Research International. 3/20/2016, Vol. 2016, p1-11. 11p.

Deficiency in Dipeptidyl Peptidase-4 Promotes Chemoresistance Through the CXCL12/CXCR4/mTOR/TGFβ Signaling Pathway in Breast Cancer Cells.

Authors: Li, Shaolan Fan, Yang Kumagai, Asako et al.

Source: International Journal of Molecular Sciences. 2/1/2020, Vol. 21 Issue 3, p805. 1p. 5 Graphs.